UniProt ID | SYRC_HUMAN | |
---|---|---|
UniProt AC | P54136 | |
Protein Name | Arginine--tRNA ligase, cytoplasmic | |
Gene Name | RARS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 660 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cytosol . | |
Protein Description | Forms part of a macromolecular complex that catalyzes the attachment of specific amino acids to cognate tRNAs during protein synthesis. [PubMed: 25288775 Modulates the secretion of AIMP1 and may be involved in generation of the inflammatory cytokine EMAP2 from AIMP1] | |
Protein Sequence | MDVLVSECSARLLQQEEEIKSLTAEIDRLKNCGCLGASPNLEQLQEENLKLKYRLNILRKSLQAERNKPTKNMINIISRLQEVFGHAIKAAYPDLENPPLLVTPSQQAKFGDYQCNSAMGISQMLKTKEQKVNPREIAENITKHLPDNECIEKVEIAGPGFINVHLRKDFVSEQLTSLLVNGVQLPALGENKKVIVDFSSPNIAKEMHVGHLRSTIIGESISRLFEFAGYDVLRLNHVGDWGTQFGMLIAHLQDKFPDYLTVSPPIGDLQVFYKESKKRFDTEEEFKKRAYQCVVLLQGKNPDITKAWKLICDVSRQELNKIYDALDVSLIERGESFYQDRMNDIVKEFEDRGFVQVDDGRKIVFVPGCSIPLTIVKSDGGYTYDTSDLAAIKQRLFEEKADMIIYVVDNGQSVHFQTIFAAAQMIGWYDPKVTRVFHAGFGVVLGEDKKKFKTRSGETVRLMDLLGEGLKRSMDKLKEKERDKVLTAEELNAAQTSVAYGCIKYADLSHNRLNDYIFSFDKMLDDRGNTAAYLLYAFTRIRSIARLANIDEEMLQKAARETKILLDHEKEWKLGRCILRFPEILQKILDDLFLHTLCDYIYELATAFTEFYDSCYCVEKDRQTGKILKVNMWRMLLCEAVAAVMAKGFDILGIKPVQRM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDVLVSEC -------CCHHHHHH | 7.89 | 22223895 | |
6 | Phosphorylation | --MDVLVSECSARLL --CCHHHHHHHHHHH | 28.82 | 20860994 | |
20 | Ubiquitination | LQQEEEIKSLTAEID HHCHHHHHHHHHHHH | 42.57 | 21890473 | |
20 | 2-Hydroxyisobutyrylation | LQQEEEIKSLTAEID HHCHHHHHHHHHHHH | 42.57 | - | |
20 | Ubiquitination | LQQEEEIKSLTAEID HHCHHHHHHHHHHHH | 42.57 | 22053931 | |
20 (in isoform 1) | Ubiquitination | - | 42.57 | 21890473 | |
20 | Ubiquitination | LQQEEEIKSLTAEID HHCHHHHHHHHHHHH | 42.57 | 21890473 | |
21 | Phosphorylation | QQEEEIKSLTAEIDR HCHHHHHHHHHHHHH | 36.29 | 25159151 | |
30 | 2-Hydroxyisobutyrylation | TAEIDRLKNCGCLGA HHHHHHHHCCCCCCC | 51.60 | - | |
30 | Acetylation | TAEIDRLKNCGCLGA HHHHHHHHCCCCCCC | 51.60 | 26051181 | |
30 | Ubiquitination | TAEIDRLKNCGCLGA HHHHHHHHCCCCCCC | 51.60 | 32015554 | |
38 | Phosphorylation | NCGCLGASPNLEQLQ CCCCCCCCCCHHHHH | 16.72 | 25159151 | |
50 | Acetylation | QLQEENLKLKYRLNI HHHHHCHHHHHHHHH | 55.29 | 25953088 | |
50 | Ubiquitination | QLQEENLKLKYRLNI HHHHHCHHHHHHHHH | 55.29 | 32015554 | |
60 | Acetylation | YRLNILRKSLQAERN HHHHHHHHHHHHHHC | 52.66 | 19608861 | |
61 | Phosphorylation | RLNILRKSLQAERNK HHHHHHHHHHHHHCC | 21.19 | 26699800 | |
71 | Ubiquitination | AERNKPTKNMINIIS HHHCCCCHHHHHHHH | 53.71 | 24816145 | |
73 | Sulfoxidation | RNKPTKNMINIISRL HCCCCHHHHHHHHHH | 2.37 | 28183972 | |
103 | Phosphorylation | ENPPLLVTPSQQAKF CCCCEEECHHHHCCC | 19.72 | 25850435 | |
105 | Phosphorylation | PPLLVTPSQQAKFGD CCEEECHHHHCCCCC | 26.09 | 25850435 | |
115 | Glutathionylation | AKFGDYQCNSAMGIS CCCCCCCCHHHHHHH | 3.37 | 22555962 | |
126 | Ubiquitination | MGISQMLKTKEQKVN HHHHHHHHCCCCCCC | 52.81 | 32015554 | |
133 (in isoform 2) | Ubiquitination | - | 36.63 | 21890473 | |
143 | Trimethylation | EIAENITKHLPDNEC HHHHHHHHHCCCCHH | 39.07 | - | |
143 | Acetylation | EIAENITKHLPDNEC HHHHHHHHHCCCCHH | 39.07 | 25953088 | |
143 | Methylation | EIAENITKHLPDNEC HHHHHHHHHCCCCHH | 39.07 | - | |
143 | Ubiquitination | EIAENITKHLPDNEC HHHHHHHHHCCCCHH | 39.07 | 29967540 | |
150 | Glutathionylation | KHLPDNECIEKVEIA HHCCCCHHEEEEEEC | 6.45 | 22555962 | |
153 | Acetylation | PDNECIEKVEIAGPG CCCHHEEEEEECCCC | 25.84 | 26051181 | |
193 | Ubiquitination | PALGENKKVIVDFSS CCCCCCCEEEEECCC | 49.10 | 29967540 | |
199 | Phosphorylation | KKVIVDFSSPNIAKE CEEEEECCCCCHHHH | 40.18 | 25627689 | |
200 | Phosphorylation | KVIVDFSSPNIAKEM EEEEECCCCCHHHHC | 23.20 | 25159151 | |
202 (in isoform 2) | Ubiquitination | - | 49.12 | 21890473 | |
205 | Ubiquitination | FSSPNIAKEMHVGHL CCCCCHHHHCCHHHH | 52.34 | 21890473 | |
205 | Acetylation | FSSPNIAKEMHVGHL CCCCCHHHHCCHHHH | 52.34 | 23954790 | |
205 | Malonylation | FSSPNIAKEMHVGHL CCCCCHHHHCCHHHH | 52.34 | 26320211 | |
205 | Ubiquitination | FSSPNIAKEMHVGHL CCCCCHHHHCCHHHH | 52.34 | 23000965 | |
205 (in isoform 1) | Ubiquitination | - | 52.34 | 21890473 | |
205 | Ubiquitination | FSSPNIAKEMHVGHL CCCCCHHHHCCHHHH | 52.34 | 21890473 | |
207 | Sulfoxidation | SPNIAKEMHVGHLRS CCCHHHHCCHHHHHH | 2.82 | 30846556 | |
215 | Phosphorylation | HVGHLRSTIIGESIS CHHHHHHHHHHHHHH | 15.35 | 21712546 | |
230 | Phosphorylation | RLFEFAGYDVLRLNH HHHHHCCCCEEECCC | 10.23 | - | |
263 | Phosphorylation | FPDYLTVSPPIGDLQ CCCCEEECCCCCCCH | 21.52 | - | |
274 | Ubiquitination | GDLQVFYKESKKRFD CCCHHHHHHHHHCCC | 44.01 | 22817900 | |
274 (in isoform 1) | Ubiquitination | - | 44.01 | 21890473 | |
275 (in isoform 2) | Ubiquitination | - | 57.31 | 21890473 | |
277 | Ubiquitination | QVFYKESKKRFDTEE HHHHHHHHHCCCCHH | 49.40 | 22817900 | |
278 | Malonylation | VFYKESKKRFDTEEE HHHHHHHHCCCCHHH | 68.52 | 26320211 | |
278 | Ubiquitination | VFYKESKKRFDTEEE HHHHHHHHCCCCHHH | 68.52 | 22817900 | |
279 | Methylation | FYKESKKRFDTEEEF HHHHHHHCCCCHHHH | 38.11 | 115490337 | |
282 | Phosphorylation | ESKKRFDTEEEFKKR HHHHCCCCHHHHHHH | 42.45 | 20068231 | |
287 | 2-Hydroxyisobutyrylation | FDTEEEFKKRAYQCV CCCHHHHHHHHHHHE | 44.63 | - | |
287 | Acetylation | FDTEEEFKKRAYQCV CCCHHHHHHHHHHHE | 44.63 | 23954790 | |
287 | Ubiquitination | FDTEEEFKKRAYQCV CCCHHHHHHHHHHHE | 44.63 | 24816145 | |
288 | Acetylation | DTEEEFKKRAYQCVV CCHHHHHHHHHHHEE | 47.81 | 25953088 | |
290 (in isoform 2) | Ubiquitination | - | 13.97 | 21890473 | |
291 | Phosphorylation | EEFKKRAYQCVVLLQ HHHHHHHHHHEEEEC | 13.38 | 28152594 | |
293 | Glutathionylation | FKKRAYQCVVLLQGK HHHHHHHHEEEECCC | 1.17 | 22555962 | |
300 | 2-Hydroxyisobutyrylation | CVVLLQGKNPDITKA HEEEECCCCCCHHHH | 52.96 | - | |
300 | Acetylation | CVVLLQGKNPDITKA HEEEECCCCCCHHHH | 52.96 | 26051181 | |
300 | Ubiquitination | CVVLLQGKNPDITKA HEEEECCCCCCHHHH | 52.96 | - | |
306 | Acetylation | GKNPDITKAWKLICD CCCCCHHHHHHHHHH | 53.21 | 26051181 | |
306 | Ubiquitination | GKNPDITKAWKLICD CCCCCHHHHHHHHHH | 53.21 | 29967540 | |
309 | Acetylation | PDITKAWKLICDVSR CCHHHHHHHHHHHCH | 32.60 | 25953088 | |
321 | Ubiquitination | VSRQELNKIYDALDV HCHHHHHHHHHHHCH | 56.09 | 29967540 | |
321 (in isoform 2) | Ubiquitination | - | 56.09 | 21890473 | |
329 | Phosphorylation | IYDALDVSLIERGES HHHHHCHHHHHCCCC | 24.24 | 26270265 | |
338 | Phosphorylation | IERGESFYQDRMNDI HHCCCCHHHHHHHHH | 20.84 | - | |
341 | Methylation | GESFYQDRMNDIVKE CCCHHHHHHHHHHHH | 15.41 | 115490329 | |
342 | Sulfoxidation | ESFYQDRMNDIVKEF CCHHHHHHHHHHHHH | 7.70 | 21406390 | |
347 | 2-Hydroxyisobutyrylation | DRMNDIVKEFEDRGF HHHHHHHHHHHHCCC | 57.95 | - | |
347 | Acetylation | DRMNDIVKEFEDRGF HHHHHHHHHHHHCCC | 57.95 | 26051181 | |
347 | Ubiquitination | DRMNDIVKEFEDRGF HHHHHHHHHHHHCCC | 57.95 | 21906983 | |
347 (in isoform 1) | Ubiquitination | - | 57.95 | 21890473 | |
352 | Methylation | IVKEFEDRGFVQVDD HHHHHHHCCCEEECC | 33.00 | 115490321 | |
362 | Ubiquitination | VQVDDGRKIVFVPGC EEECCCCEEEEECCC | 49.07 | 21890473 | |
362 | Neddylation | VQVDDGRKIVFVPGC EEECCCCEEEEECCC | 49.07 | 32015554 | |
362 | Ubiquitination | VQVDDGRKIVFVPGC EEECCCCEEEEECCC | 49.07 | 23000965 | |
362 (in isoform 1) | Ubiquitination | - | 49.07 | 21890473 | |
362 | Ubiquitination | VQVDDGRKIVFVPGC EEECCCCEEEEECCC | 49.07 | 21890473 | |
369 | S-nitrosocysteine | KIVFVPGCSIPLTIV EEEEECCCCCEEEEE | 2.46 | - | |
369 | Glutathionylation | KIVFVPGCSIPLTIV EEEEECCCCCEEEEE | 2.46 | 22555962 | |
369 | S-nitrosylation | KIVFVPGCSIPLTIV EEEEECCCCCEEEEE | 2.46 | 19483679 | |
369 | S-palmitoylation | KIVFVPGCSIPLTIV EEEEECCCCCEEEEE | 2.46 | 29575903 | |
370 | Phosphorylation | IVFVPGCSIPLTIVK EEEECCCCCEEEEEE | 32.91 | 28348404 | |
374 | Phosphorylation | PGCSIPLTIVKSDGG CCCCCEEEEEECCCC | 20.54 | 28102081 | |
377 | Acetylation | SIPLTIVKSDGGYTY CCEEEEEECCCCCEE | 38.69 | 23236377 | |
377 | Malonylation | SIPLTIVKSDGGYTY CCEEEEEECCCCCEE | 38.69 | 26320211 | |
377 | Ubiquitination | SIPLTIVKSDGGYTY CCEEEEEECCCCCEE | 38.69 | 33845483 | |
378 | Phosphorylation | IPLTIVKSDGGYTYD CEEEEEECCCCCEEE | 30.50 | 28152594 | |
382 | Phosphorylation | IVKSDGGYTYDTSDL EEECCCCCEEEHHHH | 13.99 | 28152594 | |
383 | Phosphorylation | VKSDGGYTYDTSDLA EECCCCCEEEHHHHH | 20.42 | 28152594 | |
384 | Phosphorylation | KSDGGYTYDTSDLAA ECCCCCEEEHHHHHH | 14.56 | 28152594 | |
386 | Phosphorylation | DGGYTYDTSDLAAIK CCCCEEEHHHHHHHH | 17.46 | 28152594 | |
387 | Phosphorylation | GGYTYDTSDLAAIKQ CCCEEEHHHHHHHHH | 27.94 | 28152594 | |
393 | Ubiquitination | TSDLAAIKQRLFEEK HHHHHHHHHHHHHHC | 25.33 | 21890473 | |
393 | 2-Hydroxyisobutyrylation | TSDLAAIKQRLFEEK HHHHHHHHHHHHHHC | 25.33 | - | |
393 | Acetylation | TSDLAAIKQRLFEEK HHHHHHHHHHHHHHC | 25.33 | 27452117 | |
393 | Ubiquitination | TSDLAAIKQRLFEEK HHHHHHHHHHHHHHC | 25.33 | 23000965 | |
393 (in isoform 1) | Ubiquitination | - | 25.33 | 21890473 | |
393 | Ubiquitination | TSDLAAIKQRLFEEK HHHHHHHHHHHHHHC | 25.33 | 21890473 | |
399 (in isoform 2) | Ubiquitination | - | 46.33 | 21890473 | |
449 | Ubiquitination | GVVLGEDKKKFKTRS CEEECCCHHHCCCCC | 54.27 | 33845483 | |
450 (in isoform 2) | Ubiquitination | - | 75.63 | 21890473 | |
451 | Acetylation | VLGEDKKKFKTRSGE EECCCHHHCCCCCCC | 58.81 | 7681275 | |
453 | Acetylation | GEDKKKFKTRSGETV CCCHHHCCCCCCCCH | 52.49 | 7681285 | |
459 | Phosphorylation | FKTRSGETVRLMDLL CCCCCCCCHHHHHHH | 17.91 | - | |
463 | Sulfoxidation | SGETVRLMDLLGEGL CCCCHHHHHHHHHHH | 2.09 | 21406390 | |
471 | 2-Hydroxyisobutyrylation | DLLGEGLKRSMDKLK HHHHHHHHHHHHHHH | 53.97 | - | |
471 | Ubiquitination | DLLGEGLKRSMDKLK HHHHHHHHHHHHHHH | 53.97 | 21906983 | |
471 (in isoform 1) | Ubiquitination | - | 53.97 | 21890473 | |
472 | Dimethylation | LLGEGLKRSMDKLKE HHHHHHHHHHHHHHH | 42.11 | - | |
472 | Methylation | LLGEGLKRSMDKLKE HHHHHHHHHHHHHHH | 42.11 | 18938727 | |
476 | Ubiquitination | GLKRSMDKLKEKERD HHHHHHHHHHHHHHH | 53.47 | 22817900 | |
480 | Ubiquitination | SMDKLKEKERDKVLT HHHHHHHHHHHHCCC | 57.36 | 24816145 | |
484 | 2-Hydroxyisobutyrylation | LKEKERDKVLTAEEL HHHHHHHHCCCHHHH | 45.42 | - | |
485 (in isoform 2) | Ubiquitination | - | 7.23 | 21890473 | |
496 | Phosphorylation | EELNAAQTSVAYGCI HHHHHHHHHHHHCCH | 22.05 | 28152594 | |
497 | Phosphorylation | ELNAAQTSVAYGCIK HHHHHHHHHHHCCHH | 7.83 | 28152594 | |
500 | Phosphorylation | AAQTSVAYGCIKYAD HHHHHHHHCCHHHHH | 15.46 | 28152594 | |
502 | Glutathionylation | QTSVAYGCIKYADLS HHHHHHCCHHHHHCC | 1.26 | 22555962 | |
504 | Acetylation | SVAYGCIKYADLSHN HHHHCCHHHHHCCCC | 38.16 | 26051181 | |
504 | Ubiquitination | SVAYGCIKYADLSHN HHHHCCHHHHHCCCC | 38.16 | 21963094 | |
505 | Phosphorylation | VAYGCIKYADLSHNR HHHCCHHHHHCCCCC | 5.85 | 28152594 | |
516 | Phosphorylation | SHNRLNDYIFSFDKM CCCCCHHEEEEHHHH | 11.64 | 28152594 | |
519 | Phosphorylation | RLNDYIFSFDKMLDD CCHHEEEEHHHHHCC | 23.99 | 21712546 | |
522 | Acetylation | DYIFSFDKMLDDRGN HEEEEHHHHHCCCCC | 39.08 | 26822725 | |
522 | Ubiquitination | DYIFSFDKMLDDRGN HEEEEHHHHHCCCCC | 39.08 | 21906983 | |
522 (in isoform 1) | Ubiquitination | - | 39.08 | 21890473 | |
536 | Phosphorylation | NTAAYLLYAFTRIRS CHHHHHHHHHHHHHH | 9.32 | 22817900 | |
554 | Sulfoxidation | LANIDEEMLQKAARE HCCCCHHHHHHHHHH | 4.52 | 21406390 | |
557 | 2-Hydroxyisobutyrylation | IDEEMLQKAARETKI CCHHHHHHHHHHHCC | 39.80 | - | |
557 | Acetylation | IDEEMLQKAARETKI CCHHHHHHHHHHHCC | 39.80 | 27452117 | |
557 | Ubiquitination | IDEEMLQKAARETKI CCHHHHHHHHHHHCC | 39.80 | 21963094 | |
557 (in isoform 1) | Ubiquitination | - | 39.80 | 21890473 | |
563 | 2-Hydroxyisobutyrylation | QKAARETKILLDHEK HHHHHHHCCCCCCHH | 26.97 | - | |
563 | Ubiquitination | QKAARETKILLDHEK HHHHHHHCCCCCCHH | 26.97 | 33845483 | |
570 | Acetylation | KILLDHEKEWKLGRC CCCCCCHHHHHHHHH | 66.51 | 23236377 | |
570 | Ubiquitination | KILLDHEKEWKLGRC CCCCCCHHHHHHHHH | 66.51 | 29967540 | |
573 | Acetylation | LDHEKEWKLGRCILR CCCHHHHHHHHHHHH | 42.00 | 26051181 | |
573 | Ubiquitination | LDHEKEWKLGRCILR CCCHHHHHHHHHHHH | 42.00 | 27667366 | |
583 (in isoform 2) | Ubiquitination | - | 54.33 | 21890473 | |
629 | Acetylation | RQTGKILKVNMWRML CCCCCEEEHHHHHHH | 34.73 | 25953088 | |
638 | Glutathionylation | NMWRMLLCEAVAAVM HHHHHHHHHHHHHHH | 2.51 | 22555962 | |
655 | Ubiquitination | GFDILGIKPVQRM-- CCCCCCCCCCCCC-- | 37.02 | 23000965 | |
655 (in isoform 1) | Ubiquitination | - | 37.02 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SYRC_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYRC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYRC_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
616140 | Leukodystrophy, hypomyelinating, 9 (HLD9) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-38, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60 AND LYS-205, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-38, AND MASS SPECTROMETRY. |